CervoMed
CRVO
22 hedge funds and large institutions have $4.3M invested in CervoMed in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 8 closing their positions.
0% more funds holding
Funds holding: 22 → 22 (0)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
0.01% less ownership
Funds ownership: 0.12% → 0.11% (-0.01%)
16% less capital invested
Capital invested by funds: $5.14M → $4.3M (-$844K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$99.4K |
| 2 |
VF
Virtu Financial
New York
|
+$98.2K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$53.4K |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$40.5K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$34.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$160K |
| 2 |
Jane Street
New York
|
-$113K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$85.3K |
| 4 |
HF
HRT Financial
New York
|
-$60K |
| 5 |
SAMH
Shanda Asset Management Holdings
Tortola,,
British Virgin Islands
|
-$59K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FIA
26
FNY Investment Advisers
New York
| – | -$13K | -186 | Closed |
|
|
IA
27
IFP Advisors
Tampa,
Florida
| – | -$14K | -184 | Closed |
|
|
ECM
28
ETrade Capital Management
Arlington,
Virginia
| – | -$11K | -146 | Closed |
|
|
VNA
29
Valley National Advisers
Bethlehem,
Pennsylvania
| – | -$1K | -13 | Closed |
|
30
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$1K | -9 | Closed |
|
CRVO Hedge Fund Activity: Q3 2020 in Review
22 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q3 2020, worth a combined $4.3M — down 16% from $5.14M a quarter earlier.
Fund positioning in CRVO was balanced in Q3 2020: 8 funds opened new positions, 8 closed out, 6 added to existing stakes and 6 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $99.4K. The largest seller was Renaissance Technologies, cutting an estimated $160K.
- 22 institutional investors held CervoMed (CRVO) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $4.3M of CervoMed stock for Q3 2020, down 16% quarter-over-quarter.
- 8 funds opened new CervoMed positions in Q3 2020 and 8 closed out, a net change of 0 holders.
- The largest CervoMed buyer in Q3 2020 was Goldman Sachs, an estimated $99.4K added.
- The largest CervoMed seller in Q3 2020 was Renaissance Technologies, an estimated $160K sold.
Based on aggregated 13F filings for Q3 2020.